Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: A prospective randomised trial

Lancet

Volumn 354, Issue 9182, 1999, Pages 885-890

  Burkhoff, Daniel ^a   Schmidt, Sheila ^b   Schulman, Steven P ^c   Myers, Jonathan ^d   Resar, Jon ^c   Becker, Lewis C ^c   Weiss, James ^c   Jones, James W ^b  

^a Columbia University ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPYRIDAMOLE; GLYCERYL TRINITRATE; NITRATE; THALLIUM;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART MUSCLE REVASCULARIZATION; HOLMIUM LASER; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL DRUG ADMINISTRATION; TREATMENT OUTCOME; UNITED STATES;

EID: 0033546967     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)08113-1     Document Type: Article

References (25)

1. Mirhoseini M., Shelgikar S., Cayton M.M. New concepts in revascularization of the myocardium. Ann Thorac Surg. 45:1988;415-420.
2. Frazier O.H., Cooley D.A., Kadipasaoglu K.A.et al. Myocardial revascularization with laser: preliminary findings. Circulation. 92( suppl II):1995;58-65.
3. Cooley D.A., Frazier O.H., Kadipasaoglu K.A.et al. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg. 111:1996;791-799.
4. Horvath K.A., Mannting F., Cummings N., Shernan S.K., Cohn L.H. Transmyocardial laser revascularization: operative techniques and clinical results at two years. J Thorac Cardiovasc Surg. 111:1996;1047-1053.
5. Horvath K.A., Cohn L.H., Cooley D.A.et al. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg. 113:1997;645-654.
6. Schofield P.M., Sharples L.D., Caine N.et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet. 353:1999;519-524.
7. Burkhoff D., Wesley M.N., Resar J.R., Lansing A.M. Factors correlating with risk of mortality following transmyocardial revascularization. J Am Col Cardiol. 34:1999;55-61.
8. Hardy R.I., Bove K.E., James F.W., Kaplan S., Goldman L. A histologic study of laser induced transmyocardial channels. Lasers Surg Med. 6:1987;563-573.
9. Packer M. The placebo effect in heart failure. Am Heart J. 120:1990;1578-1582.
10. Cooley D.A., Frazier O.H., Kadipasaoglu K.A., Pehlivanoglu S., Shannon R.L., Angelini P. Transmyocardial laser revascularization: anatomic evidence of long-term channel patency. Texas Heart Inst J. 21:1994;220-224.
11. Horvath K.A., Smith W.J., Laurence R.G., Schoen F.J., Appleyard R.F., Cohn L.H. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol. 25:1995;258-263.
12. Mirhoseini M., Shelgikar S., Cayton M. Clinical and histological evaluation of laser myocardial revascularization. J Clin Laser Med Surg. 8:1990;73-78.
13. Yano O.J., Bielefeld M.R., Jeevanandam V.et al. Prevention of acute regional ischemia with endocardial laser channels. Ann Thorac Surg. 56:1993;46-53.
14. Burkhoff D., Fisher P.E., Apfelbaum M., Kohmoto T., DeRosa C.M., Smith C.R. Histologic appearance of transmyocardial laser channels after 4-1/2 weeks. Ann Thorac Surg. 61:1996;1532-1535.
15. Burkhoff D., Fulton R., Wharton K., Billingham M.E., Robbins R. Myocardial perfusion through naturally occurring subendocardial channels. J Thorac Cardiovasc Surg. 114:1997;497-499.
16. 2 and Holmium:YAG lasers. Ann Thorac Surg. 64:1997;466-472.
17. 2 laser. Ann Thorac Surg. 63:1997;1275-1283.
18. Krabatsch T., Schaper F., Leder C., Tulsner J., Thalmann U., Hetzer R. Histological findings after transmyocardial laser revascularization. J Cardiac Surg. 11:1996;326-331.
19. Pifarre R., Jasuja M.L., Lynch R.D., Neville W.E. Myocardial revascularization by transmyocardial acupuncture: a physiologic impossibility. J Thorac Cardiovasc Surg. 58:1969;424-431.
20. Kohmoto T., Uzun G., Gu A., Zhu S.M., Smith C.R., Burkhoff D. Blood flow capacity via direct acute myocardial revascularization. Basic Res Cardiol. 92:1997;45-51.
21. Whittaker P., Kloner R.A., Przyklenk K. Laser-mediated transmural myocardial channels do not salvage acutely ischemic myocardium. J Am Coll Cardiol. 22:1993;302-309.
22. Kohmoto T., DeRosa C., Yamamoto N., Fisher P.E., Smith C.R., Burkhoff D. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg. 65:1998;1360-1367.
23. Yamamoto N., Kohmoto T., Gu A., DeRosa C.M., Smith C.R., Burkhoff D. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol. 31:1998;1426-1433.
24. Ware J.A., Simons M. Angiogenesis in ischemic heart disease. Nat Med. 3:1997;158-164.
25. Kwong K.F., Kanellopoulos G.K., Nickols J.C.et al. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg. 114:1997;883-889.